RMD Q3 2020 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q3 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$769M+16.2% YoY

Gross Profit

$450M58.4% margin

Operating Income

$218M28.3% margin

Net Income

$163M21.2% margin

EPS (Diluted)

$1.12

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$240M

Free Cash Flow

$208M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$4.5B

Total Liabilities

$2.3B

Stockholders' Equity

$2.3B

Cash & Equivalents

$353M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$769M	$662M	+16.2%
Gross Profit	$450M	$392M	+14.7%
Operating Income	$218M	$157M	+38.6%
Net Income	$163M	$105M	+54.8%

Revenue Segments

Devices And Masks

$680M88%

Software As Service

$90M12%

Geographic Segments

Us Canada And Latin America

$483M63%

Combined Europe Asia And Other Markets

$286M37%